Press Release: Premas Biotech : Premas Biotech Announces Approval to Initiate Phase 1 Trials in South Africa, for Oravax's Oral Vaccine for COVID-19

Business Wire IndiaPremas Biotech, a developer of novel biotherapeutic and vaccine candidates, today announced that Oravax Medical Inc., a US based company that Premas Biotech is a partner in, has received clearance from the South African Health Products Regulatory Authority to commence patient enrollment in a first in human, Phase 1 clinical trial, for its oral COVID-19 vaccine; and preparations to begin the trials are now underway.